Commit b1dd370f authored by Mathieu Giraud's avatar Mathieu Giraud

doc/credits.md: some other publication, details

parent 2319188f
Pipeline #169563 passed with stages
in 3 minutes and 26 seconds
......@@ -107,6 +107,11 @@ Sébastien Bender et al.,
Blood, 2020,
<https://doi.org/10.1182/blood.2019004197>
Monila Brüggemann et al., on behalf of the EuroClonality-NGS working group,
*Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study*
Leukemia, 2019, 33, 2241–2253,
<https://doi.org/10.1038/s41375-019-0496-7>
Roberta Cavagna et al.,
*Capture-based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes*
Cancers, 2020, 12(6), 1505,
......@@ -145,7 +150,7 @@ British Journal of Haematology, 2020,
Kenji Kimura et al.,
*Identification of Clonal Immunoglobulin λ Light-Chain Gene Rearrangements in AL Amyloidosis Using Next Generation Sequencing*,
ASH 2019,
ASH 2019, Blood,
<https://doi.org/10.1182/blood-2019-125028>
Michaela Kotrova et al.,
......@@ -174,8 +179,8 @@ Leukemia Research, 2017, 53, 1–7
<http://dx.doi.org/10.1016/j.leukres.2016.11.009>
Masashi Sanada et al.,
*Targeted-Capture Sequencing Is a Useful Method for MRD Markers Screening in KMT2A (MLL) Rearranged Leukemia*
Blood, 2019, 134(S1):2759
*Targeted-Capture Sequencing Is a Useful Method for MRD Markers Screening in KMT2A (MLL) Rearranged Leukemia*,
ASH 2019, Blood, 134(S1):2759
<https://doi.org/10.1182/blood-2019-125421>
Florian Scherer et al.,
......
Markdown is supported
0% or
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment